China Traditional Chinese Medicine Holdings Co. Limited (00570.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.8x

Market Cap

HKD 6.77B

MomentumView details →

1D Return

+1.89%

YTD Return

−35.65%

RSI (14)

37.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.8x

Market Cap

HKD 6.77B

RSI (14)

37.6

MomentumView details →

1D Return

+1.89%

YTD Return

−35.65%

ProfitabilityView details →

Gross Margin

47.57%

Net Margin

−4.48%

EBITDA Margin

9.93%

ROE (TTM)

−6.42%

ROA (TTM)

−4.23%

Asset Turnover

0.91x

GrowthView details →

Revenue YoY

−19.10%

EPS YoY

—

FCF YoY

+23.64%

Revenue CAGR 3Y

+1.02%

EPS CAGR 3Y

—

EBITDA YoY

−37.52%

EarningsView details →

EPS (Actual)

−HKD 0.18

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

2.76x

Quick Ratio

2.13x

Div Yield

—

Div Rate

—

Div Growth 1Y

+66.99%

Financials snapshotView financials →

Revenue (TTM)

28.23B

Net Income (TTM)

−1.26B

Op. CF (TTM)

—

Next earningsMar 19, 2027 →

Latest newsMore news →

China Traditional Chinese Medicine Holdings announced that its subsidiary Tongjitang Pharmaceutical's Class 1.1 innovative traditional Chinese medicine drug Xingpi Jieyu Tablets (formerly Yusuda Tablets) has been approved for market launch by the National Medical Products Administration.11h ago

China Traditional Chinese Medicine Holdings Co Ltd (00570) released its interim results for the six months ended June 30, 2026, reporting a net loss attributable to shareholders of RMB 776 million, a year-on-year increase of 619.3%, and revenue of RMB 5.438 billion, down 27.1% year-on-year.7d ago

Similar companies

康缘药业600557.SH 百克生物688276.SH 中牧股份600195.SH 中恒集团600252.SH Lantheus Holdings, Inc.LNTH 亚虹医药-U688176.SH Find similar companies →

Latest newsMore news →

China Traditional Chinese Medicine Holdings announced that its subsidiary Tongjitang Pharmaceutical's Class 1.1 innovative traditional Chinese medicine drug Xingpi Jieyu Tablets (formerly Yusuda Tablets) has been approved for market launch by the National Medical Products Administration.11h ago China Traditional Chinese Medicine Holdings Co Ltd (00570) released its interim results for the six months ended June 30, 2026, reporting a net loss attributable to shareholders of RMB 776 million, a year-on-year increase of 619.3%, and revenue of RMB 5.438 billion, down 27.1% year-on-year.7d ago